Hematology

An Open-Label Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia (IRB# 34350)

Status: Completed

Investigators:

  • Moshe Bell, MD

Categories:

  • Hematology / Oncology